Life Sciences Megatenants Are In Dwindling Supply After Record Lease

That deal, combined with other Big Pharma leases in key biotech markets, sparked optimism for a beleaguered industry starved for lease commitments for more than a year.

But the number of big fish in the life sciences sea has dwindled, setting up fierce competition for huge swaths of life sciences real estate sitting empty across the country and more serious contemplation of seeking out nonbiotech tenants.

“There are not that many more whales looking for space, okay?” JLL Vice Chairman Chad Urie said. “If you look at pharma presence in San Diego, it`s pretty easy to see that a good percentage of those groups have made their real estate play.”...   ...more

RSK: This has become a nationwide problem for some reason. Looks like lab companies are putting more money into research rather than leases. I haven`t seen any action at Velocity Station in Madison to date.